Analysis of apoptosis-related genes, including BAX, BCL2, and CASP3 expression, suggested that the combination therapy did not have more effect in inducing apoptotic pathways in both cancer and normal cell lines in comparison with CAP or CUR alone. Here, BCL2 is linked to cancer.